Feature | February 19, 2014

Experimental Wireless Messaging Technology Remotely Monitors Patient Heart Conditions

LAPTOP-HF Telecardiology Remote Patient Monitoring ICM EP Lab Heart Failure ECG

February 19, 2014 — A new treatment option for heart disease is being tested at The University of Kansas Hospital that could be significant in telemedicine. Using an implantable monitoring device, the patient can hold a smartphone-type device to the chest and the device will relay info wirelessly from the heart implant to the doctors at the hospital. It allows doctors the ability to better personalize treatment for heart failure patients while giving those patients more control of their chronic condition.

The clinical trial is called LAPTOP-HF (Left Atrial Pressure Monitoring to Optimize Heart Failure Therapy.) Dhanunjaya Lakkireddy, an electrophysiologist at The University of Kansas Hospital, said the LAPTOP-HF monitor can give heart patients and their doctors critical information immediately. 

"Before this device, any of these measurements had to be taken here in our office. Now with this technology, we can obtain the information from the patient's home," Lakkireddy said. "It's especially helpful for patients who live a long way from us. We can constantly monitor their condition and give them medication changes any time, rather than waiting for a scheduled appointment."

That's a huge benefit for Larry Stewart, who lives nearly two hours south of the hospital in Bronson, Kan. Before enrolling in the trial, Stewart and his wife had to make the journey to see Lakkireddy about every six weeks for congestive heart failure and atrial fibrillation.

Now, after having the device (which looks like a pacemaker) surgically implanted in his chest, all Stewart has to do each day is hold the small monitor (the size of a smartphone) up to his chest and the readings are electronically sent back to the doctor's office for instant analysis. 

"It makes me feel better that there's something there that's measuring and keeping an eye on my heart," Stewart said. 

It also means only making the trip to the doctor's office every three months, while still being monitored regularly, which is especially helpful during winter months when road conditions can be dangerous. 

St. Jude Medical developed the monitor. The University of Kansas Hospital is among the 75 sites in the United States chosen to evaluate the safety and effectiveness of the device.

For more information: www.kumed.com

Related Content

Niobe remote magnetic navigation system, cardiac abltion, Robert Wood Johnson University Hospital, New Jersey, 500 procedures
News | Robotic Systems| October 25, 2016
Stereotaxis Inc. and Robert Wood Johnson University Hospital (RWJUH) announced that Zyad Younan, M.D., has completed...
UAB, University of Alabama at Birmingham study, stroke prevention, non-valvular atrial fibrillation, NVAF
News | Atrial Fibrillation| October 25, 2016
A recent study from University of Alabama at Birmingham (UAB) researchers published in PLOS ONE compares different...
iSmartweaR, smart clothing, jIndustrial Technology Research Institute, ITRI, wearable heart monitoring

An example of an iSmartweaR shirt that can monitor patient vital signs without the need for electrode wires.

News | Wearable Sensors| October 24, 2016
October 24, 2016 — Conventional smart clothing uses conductive fibers or rubber as sensing electrodes, and cardiac el
Inventory management, Cardinal, RFID inventory tracking, cath lab inventory
Sponsored Content | Whitepapers | Inventory Management| October 18, 2016
As healthcare moves into the era of bundled payments, providers need to be especially focused on ensuring delivery of
Medtronic, FIRE AND ICE trial, Arctic Front, cryoballoon catheter ablation, radiofrequency RF ablation, study results, Asia Pacific Heart Rhythm Society Scientific Sessions
News | Ablation Systems| October 17, 2016
Medtronic plc last week unveiled new health economic analysis data from the FIRE AND ICE trial that favor cryoballoon...
News | Wearable Sensors| October 13, 2016
Biotricity Inc. announced recently that it will be expanding its existing research partnership with the University of...
Medtronic, FDA approval, MRI, MR-conditional scanning, cardiac devices
Technology | EP Lab| October 13, 2016
Medtronic plc is the first company to receive U.S. Food and Drug Administration (FDA) approval for its suite of cardiac...
News | Renal Denervation| October 11, 2016
Awards from the National Institutes of Health’s Common Fund are supporting research on the peripheral nervous system,...
Overlay Init